Veit Zebralla

642 total citations
38 papers, 238 citations indexed

About

Veit Zebralla is a scholar working on Otorhinolaryngology, Oncology and Surgery. According to data from OpenAlex, Veit Zebralla has authored 38 papers receiving a total of 238 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Otorhinolaryngology, 19 papers in Oncology and 10 papers in Surgery. Recurrent topics in Veit Zebralla's work include Head and Neck Cancer Studies (22 papers), Cancer survivorship and care (9 papers) and Dysphagia Assessment and Management (7 papers). Veit Zebralla is often cited by papers focused on Head and Neck Cancer Studies (22 papers), Cancer survivorship and care (9 papers) and Dysphagia Assessment and Management (7 papers). Veit Zebralla collaborates with scholars based in Germany and Austria. Veit Zebralla's co-authors include Andreas Dietz, Gunnar Wichmann, Susanne Wiegand, Thomas Neumuth, Markus Pirlich, Anja Mehnert, Andreas Hinz, Thomas Berger, K. W. Zimmermann and Susanne Singer and has published in prestigious journals such as Frontiers in Immunology, International Journal of Environmental Research and Public Health and BMC Cancer.

In The Last Decade

Veit Zebralla

34 papers receiving 235 citations

Peers

Veit Zebralla
Bena Brown Australia
Markus Pirlich Germany
Kalika P. Sarma United States
Katrina Hueniken Canada
Ya‐Lan Chang Taiwan
Rob J. de Leeuw Netherlands
Jean Courquin United States
Shuai Niu China
Gemma Asín Spain
Guro Lindviksmoen Astrup Norway
Bena Brown Australia
Veit Zebralla
Citations per year, relative to Veit Zebralla Veit Zebralla (= 1×) peers Bena Brown

Countries citing papers authored by Veit Zebralla

Since Specialization
Citations

This map shows the geographic impact of Veit Zebralla's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Veit Zebralla with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Veit Zebralla more than expected).

Fields of papers citing papers by Veit Zebralla

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Veit Zebralla. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Veit Zebralla. The network helps show where Veit Zebralla may publish in the future.

Co-authorship network of co-authors of Veit Zebralla

This figure shows the co-authorship network connecting the top 25 collaborators of Veit Zebralla. A scholar is included among the top collaborators of Veit Zebralla based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Veit Zebralla. Veit Zebralla is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zebralla, Veit, et al.. (2025). The impact of financial burden on quality of life among German head and neck cancer survivors. BMC Cancer. 25(1). 514–514.
2.
Wichmann, Gunnar, Markus Pirlich, Joanna Napp, et al.. (2024). The European Larynx Organ Preservation Study [MK-3475-C44]. Frontiers in Oncology. 14. 1433238–1433238. 4 indexed citations
3.
4.
Zebralla, Veit, et al.. (2024). Cancer-associated financial burden in German head and neck cancer patients. Frontiers in Oncology. 14. 1329242–1329242. 3 indexed citations
5.
Wichmann, Gunnar, Markus Pirlich, Veit Zebralla, et al.. (2024). Improved survival of locoregional-advanced larynx and hypopharynx cancer patients treated according to the DeLOS-II protocol. Frontiers in Oncology. 14. 1394691–1394691. 4 indexed citations
6.
7.
Zebralla, Veit, Andreas Hinz, Gunnar Wichmann, Andreas Dietz, & Susanne Wiegand. (2023). Anxiety and quality of life after head and neck cancer in a longitudinal study. Laryngo-Rhino-Otologie. 102(S 02). S216–S216. 1 indexed citations
8.
Meyer, Hans‐Jonas, et al.. (2023). A Radiomics-Based Machine Learning Perspective on the Parotid Gland as a Potential Surrogate Marker for HPV in Oropharyngeal Cancer. Cancers. 15(22). 5425–5425. 1 indexed citations
9.
Wichmann, Gunnar, Ramona Landgraf, Ilias I.N. Doxiadis, et al.. (2023). Outcome differences in HPV-driven head and neck squamous cell carcinoma attributable to altered human leukocyte antigen frequencies. Frontiers in Oncology. 13. 1212454–1212454. 2 indexed citations
10.
Zebralla, Veit, et al.. (2023). Immune checkpoint blockade induced shifts in cytokine expression patterns in peripheral blood of head and neck cancer patients are linked to outcome. Frontiers in Immunology. 14. 1237623–1237623. 3 indexed citations
11.
Prenzel, Freerk, Regina Treudler, Tobias Lipek, et al.. (2022). Invasive Growth of Ailanthus altissima Trees is Associated with a High Rate of Sensitization in Atopic Patients. Journal of Asthma and Allergy. Volume 15. 1217–1226. 10 indexed citations
12.
Bohr, Christopher, Julian Künzel, Tanja Gradistanac, et al.. (2022). Cytokine Profiles of Head and Neck Squamous Cell Carcinoma Undergoing Dual Immunotherapy With Cetuximab and Pembrolizumab Identify Interferon Gamma-Induced Protein 10 as Novel Biomarker. Frontiers in Oncology. 12. 795277–795277. 6 indexed citations
13.
Wiegand, Susanne, et al.. (2021). Choosing the Right Treatment Option for the Right R/M HNSCC Patient: Should We Adhere to PFE for First-Line Therapy?. Frontiers in Oncology. 11. 715297–715297. 1 indexed citations
14.
15.
Hinz, Andreas, Andreas Dietz, Gunnar Wichmann, et al.. (2021). Depression, anxiety, fatigue, and quality of life in a large sample of patients suffering from head and neck cancer in comparison with the general population. BMC Cancer. 21(1). 94–94. 74 indexed citations
16.
17.
Zebralla, Veit, Gunnar Wichmann, Markus Pirlich, et al.. (2021). Dysphagia, voice problems, and pain in head and neck cancer patients. European Archives of Oto-Rhino-Laryngology. 278(10). 3985–3994. 27 indexed citations
18.
Zebralla, Veit, Andreas Boehm, Gunnar Wichmann, et al.. (2020). Obtaining Patient-Reported Outcomes Electronically With “OncoFunction” in Head and Neck Cancer Patients During Aftercare. Frontiers in Oncology. 10. 549915–549915. 12 indexed citations
19.
Zebralla, Veit, et al.. (2019). Monitoring and Evaluation of Late Functional Outcome in Post-treatment Follow-Up in Clinical Routine Setting. Frontiers in Oncology. 9. 700–700. 3 indexed citations
20.
Büttner, Matthias, Veit Zebralla, Andreas Dietz, & Susanne Singer. (2017). Quality of Life Measurements: Any Value for Clinical Practice?. Current Treatment Options in Oncology. 18(5). 30–30. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bena Brown Breakdown of academic impact, for papers by Markus Pirlich Breakdown of academic impact, for papers by Kalika P. Sarma Breakdown of academic impact, for papers by Katrina Hueniken Breakdown of academic impact, for papers by Ya‐Lan Chang Breakdown of academic impact, for papers by Rob J. de Leeuw Breakdown of academic impact, for papers by Jean Courquin Breakdown of academic impact, for papers by Shuai Niu Breakdown of academic impact, for papers by Gemma Asín Breakdown of academic impact, for papers by Guro Lindviksmoen Astrup
Rankless by CCL
2026